Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results.

Böhm S, Le N, Lockley M, Brockbank E, Faruqi A, Said I, Jeyarajah A, Wuntakal R, Gilks B, Singh N.

Int J Gynecol Cancer. 2019 Jan 25. pii: ijgc-2018-000092. doi: 10.1136/ijgc-2018-000092. [Epub ahead of print]

PMID:
30683759
2.

Persistence of fimbrial tissue on the ovarian surface after salpingectomy.

Gan C, Chenoy R, Chandrasekaran D, Brockbank E, Hollingworth A, Vimplis S, Lawrence AC, Jeyarajah AR, Oram D, Deo N, Saravanamuthu J, Lam SS, Faruqi A, Singh N, Manchanda R.

Am J Obstet Gynecol. 2017 Oct;217(4):425.e1-425.e16. doi: 10.1016/j.ajog.2017.06.004. Epub 2017 Jun 10.

PMID:
28610900
3.

A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy.

Casey L, Köbel M, Ganesan R, Tam S, Prasad R, Böhm S, Lockley M, Jeyarajah AJ, Brockbank E, Faruqi A, Gilks CB, Singh N.

Histopathology. 2017 Nov;71(5):736-742. doi: 10.1111/his.13272. Epub 2017 Aug 7.

PMID:
28570008
4.

Routine Appendicectomy is Unnecessary in Mucinous Borderline Ovarian Tumors.

Muglu J, Casey L, Rather H, Makhija S, Brockbank E, Kokka F, Faruqi A, Singh N, Jeyarajah A.

Int J Gynecol Pathol. 2018 Jan;37(1):57-58. doi: 10.1097/PGP.0000000000000372. No abstract available.

PMID:
28319577
5.

Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma.

Böhm S, Montfort A, Pearce OM, Topping J, Chakravarty P, Everitt GL, Clear A, McDermott JR, Ennis D, Dowe T, Fitzpatrick A, Brockbank EC, Lawrence AC, Jeyarajah A, Faruqi AZ, McNeish IA, Singh N, Lockley M, Balkwill FR.

Clin Cancer Res. 2016 Jun 15;22(12):3025-36. doi: 10.1158/1078-0432.CCR-15-2657.

6.

An ultra-radical surgical approach for recurrent vulvar cancer involving en-bloc excision of the infra-renal aorta.

Alvarez RM, Biliatis I, Flora HS, Jeyarajah AR.

Int J Gynaecol Obstet. 2016 Mar;132(3):353-4. doi: 10.1016/j.ijgo.2015.07.025. Epub 2015 Nov 25. No abstract available.

PMID:
26679350
7.

Invasive cervical cancer in pregnancy.

La Russa M, Jeyarajah AR.

Best Pract Res Clin Obstet Gynaecol. 2016 May;33:44-57. doi: 10.1016/j.bpobgyn.2015.10.002. Epub 2015 Oct 23.

PMID:
26586539
8.

Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.

Böhm S, Faruqi A, Said I, Lockley M, Brockbank E, Jeyarajah A, Fitzpatrick A, Ennis D, Dowe T, Santos JL, Cook LS, Tinker AV, Le ND, Gilks CB, Singh N.

J Clin Oncol. 2015 Aug 1;33(22):2457-63. doi: 10.1200/JCO.2014.60.5212. Epub 2015 Jun 29.

PMID:
26124480
9.

Surgical treatment of stage IA2 cervical cancer.

Kokka F, Bryant A, Brockbank E, Jeyarajah A.

Cochrane Database Syst Rev. 2014 May 29;(5):CD010870. doi: 10.1002/14651858.CD010870.pub2. Review.

10.

Women's experiences after a radical vaginal trachelectomy for early stage cervical cancer. A descriptive phenomenological study.

Lloyd PA, Briggs EV, Kane N, Jeyarajah AR, Shepherd JH.

Eur J Oncol Nurs. 2014 Aug;18(4):362-71. doi: 10.1016/j.ejon.2014.03.014. Epub 2014 May 1.

PMID:
24794078
11.

Primary chemotherapy for inoperable ovarian, fallopian tube, or primary peritoneal cancer with or without delayed debulking surgery.

Saha A, Varughese M, Gallagher CJ, Orphanos G, Wilson P, Oram D, Jeyarajah A, Reynolds K, Shepherd J, McCormack M, Olaitan A, McDonald N, Mould T, McNeish I, Ledermann JA.

Int J Gynecol Cancer. 2012 May;22(4):566-72. doi: 10.1097/IGC.0b013e318247727f.

PMID:
22426404
12.

Ovarian recurrence from a Stage 1b1 cervical adenocarcinoma previously treated with radical vaginal trachelectomy: A case report.

Brockbank EC, Evans J, Singh N, Shepherd JH, Jeyarajah AR.

Gynecol Oncol Case Rep. 2012 Jan 16;2(2):51-3. doi: 10.1016/j.gynor.2012.01.001. eCollection 2012.

13.

Systematic (complete) para-aortic lymphadenectomy: description of a novel surgical classification with technical and anatomical considerations.

Pomel C, Naik R, Martinez A, Ferron G, Nassif J, Dauplat J, Jeyarajah A.

BJOG. 2012 Jan;119(2):249-53. doi: 10.1111/j.1471-0528.2011.03171.x. Epub 2011 Oct 21.

14.

Perforation of a malignant ovarian tumor into the recto-sigmoid colon.

Bats AS, Rockall AG, Singh N, Reznek RH, Jeyarajah A.

Acta Obstet Gynecol Scand. 2010 Oct;89(10):1362-3. doi: 10.3109/00016349.2010.501857.

PMID:
20726830
15.

The accuracy of frozen section diagnosis in apparent early ovarian cancer--results from a UK centre.

Kokka F, Singh N, Reynolds K, Oram D, Jeyarajah A, Hassan L, Akintunde AH, Hamzawala I, Okojie G, Faruqi A.

Histopathology. 2009 Dec;55(6):756-8. doi: 10.1111/j.1365-2559.2009.03435.x. No abstract available.

PMID:
20002772
16.

[Is embryologically-based surgery the future in cervical cancer?].

Bats AS, Jeyarajah A, Powell M, Lécuru F.

J Gynecol Obstet Biol Reprod (Paris). 2009 Dec;38(8):698-700. doi: 10.1016/j.jgyn.2009.09.017. Epub 2009 Nov 5. French. No abstract available.

17.

Laparoscopic assisted radical vaginal hysterectomy for cervical carcinoma: morbidity and long-term follow-up.

Mehra G, Weekes A, Vantrappen P, Visvanathan D, Jeyarajah A.

Eur J Surg Oncol. 2010 Mar;36(3):304-8. doi: 10.1016/j.ejso.2009.08.009. Epub 2009 Oct 2.

PMID:
19800194
18.

Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategies.

Warwick J, Vardaki E, Fattizzi N, McNeish I, Jeyarajah A, Oram D, Hassan L, Covens A, Duffy S, Reynolds K.

BJOG. 2009 Aug;116(9):1225-41. doi: 10.1111/j.1471-0528.2009.02213.x. Epub 2009 May 28.

19.

Obstructive uropathy secondary to parametrial metastasis: an unusual presentation of breast carcinoma.

Nair RR, Conroy MD, Jeyarajah AR.

Eur J Gynaecol Oncol. 2009;30(2):214-5.

PMID:
19480260
20.

Vulval cancer: what is an adequate surgical margin?

Balega J, Butler J, Jeyarajah A, Oram D, Shepherd J, Faruqi A, Singh N, Reynolds K.

Eur J Gynaecol Oncol. 2008;29(5):455-8.

PMID:
19051811
21.

Cervical lymphadenopathy - an unusual presentation of carcinoma of the cervix: a case report.

Manoharan M, Satyanarayana D, Jeyarajah AR.

J Med Case Rep. 2008 Jul 28;2:252. doi: 10.1186/1752-1947-2-252.

22.

Cytoreductive surgery in ovarian cancer.

Pomel C, Jeyarajah A, Oram D, Shepherd J, Milliken D, Dauplat J, Reynolds K.

Cancer Imaging. 2007 Dec 17;7:210-5. Review.

23.

Interesting case of ovarian sarcoidosis: the value of multi disciplinary team working.

Wuntakal R, Bharathan R, Rockall A, Jeyarajah A.

World J Surg Oncol. 2007 Mar 29;5:38.

24.

Metastatic lobular carcinoma of breast presenting on a routine cervical smear.

Agrawal S, Jeyarajah A, Al-Okati D, Igbokwe UO.

Cytopathology. 2006 Oct;17(5):312-3. No abstract available.

PMID:
16961666
25.

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

Menon U, Skates SJ, Lewis S, Rosenthal AN, Rufford B, Sibley K, Macdonald N, Dawnay A, Jeyarajah A, Bast RC Jr, Oram D, Jacobs IJ.

J Clin Oncol. 2005 Nov 1;23(31):7919-26.

PMID:
16258091
26.

Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.

Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, Oram DH, Jacobs IJ, Shepherd JH, Reznek RH.

J Clin Oncol. 2005 Apr 20;23(12):2813-21. Erratum in: J Clin Oncol. 2005 Jul 20;23(21):4808.

PMID:
15837995
27.

Central pelvic recurrence 7 years after radical vaginal trachelectomy.

Bali A, Weekes A, Van Trappen P, Jeyarajah A, Querleu D.

Gynecol Oncol. 2005 Mar;96(3):854-6.

PMID:
15721437
28.

Laparoscopic extraperitoneal paraaortic lymphadenectomy: a study of its applications in gynecological malignancies.

Mehra G, Weekes AR, Jacobs IJ, Visvanathan D, Menon U, Jeyarajah AR.

Gynecol Oncol. 2004 Apr;93(1):189-93.

PMID:
15047234
29.

Imaging features of aggressive angiomyxoma.

Jeyadevan NN, Sohaib SA, Thomas JM, Jeyarajah A, Shepherd JH, Fisher C.

Clin Radiol. 2003 Feb;58(2):157-62.

PMID:
12623047
30.

MR imaging of carcinoma of the vulva.

Sohaib SA, Richards PS, Ind T, Jeyarajah AR, Shepherd JH, Jacobs IJ, Reznek RH.

AJR Am J Roentgenol. 2002 Feb;178(2):373-7.

PMID:
11804896
31.

Ovarian cancer identified through screening with serum markers but not by pelvic imaging.

Woolas RP, Oram DH, Jeyarajah AR, Bast RC, Jacobs IJ.

Int J Gynecol Cancer. 1999 Nov;9(6):497-501.

PMID:
11240818
32.

Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience.

Peppercorn PD, Jeyarajah AR, Woolas R, Shepherd JH, Oram DH, Jacobs IJ, Armstrong P, Lowe D, Reznek RH.

Radiology. 1999 Aug;212(2):395-9.

PMID:
10429696
33.

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.

Menon U, Talaat A, Jeyarajah AR, Rosenthal AN, MacDonald ND, Skates SJ, Sibley K, Oram DH, Jacobs IJ.

Br J Cancer. 1999 Jul;80(10):1644-7.

34.

Increased mortality in postmenopausal women with serum CA125 elevation.

Jeyarajah AR, Ind TE, MacDonald N, Skates S, Oram DH, Jacobs IJ.

Gynecol Oncol. 1999 May;73(2):242-6.

PMID:
10329041
35.

Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women.

Jeyarajah AR, Ind TE, Skates S, Oram DH, Jacobs IJ.

Cancer. 1999 May 1;85(9):2068-72.

PMID:
10223249
36.

Screening for ovarian cancer: a pilot randomised controlled trial.

Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH.

Lancet. 1999 Apr 10;353(9160):1207-10.

PMID:
10217079
37.

Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis.

Al-Jehani RM, Jeyarajah AR, Hagen B, Hogdall EV, Oram DH, Jacobs IJ.

J Natl Cancer Inst. 1998 Apr 1;90(7):540-2. No abstract available.

PMID:
9539251
38.

Effective palliation of a colovaginal fistula using a self-expanding metal stent.

Jeyarajah AR, Shepherd JH, Fairclough PD, Patchett SE.

Gastrointest Endosc. 1997 Oct;46(4):367-9. No abstract available.

PMID:
9351046
39.

Co-existing tubal ectopic pregnancy and appendicitis--a case report.

Chia P, Jeyarajah A.

Med J Malaysia. 1996 Dec;51(4):485-7.

40.

Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer.

Jeyarajah AR, Gallagher CJ, Blake PR, Oram DH, Dowsett M, Fisher C, Oliver RT.

Gynecol Oncol. 1996 Oct;63(1):47-52.

PMID:
8898167
41.

The role of ultrasound and tumour markers in the early detection of ovarian cancer.

Oram DH, Jeyarajah AR.

Br J Obstet Gynaecol. 1994 Nov;101(11):939-45. Review. No abstract available.

PMID:
7999723

Supplemental Content

Loading ...
Support Center